Neurology Minute
The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
Latest episodes
May 7, 2025 • 3min
Neuroimmunology Update 2025: MOGAD Treatments
Dr. Justin Abbatemarco discusses updates around MOGAD treatments. Show references: https://jamanetwork.com/journals/jamaneurology/article-abstract/2822964 https://jnnp.bmj.com/content/95/11/1054
May 6, 2025 • 3min
Neuroimmunology Update 2025: Autoimmune Encephalitis Outcomes
Dr. Justin Abbatemarco discusses autoimmune encephalitis with a focus on outcomes. Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000210109 https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00463-5/abstract
May 5, 2025 • 3min
The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting
Dr. Halley Alexander discusses the Neurology Today article, “The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting,” by Gina Shaw, available in the latest issue of Neurology Today or at neurologytoday.com. Show reference: The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting
May 2, 2025 • 2min
Diagnosis of Alzheimer Disease Using Plasma Biomarkers
Dr. Greg Cooper and Dr. Joseph Therriault discuss the use of plasma biomarkers in diagnosing Alzheimer disease. Show reference: https://doi.org/10.1038/s43587-024-00731-y
May 1, 2025 • 3min
Women With Genetic Epilepsies
Dr. Halley Alexander and Dr. Paula Marques discuss sex differences in genetically determined epilepsies. Show reference: https://www.neurology.org/doi/10.1212/NXG.0000000000200233
Apr 30, 2025 • 3min
Neuroimmunology Update 2025: AQP4+ NMOSD Treatment Landscape
Dr. Justin Abbatemarco discusses updates around treatments in AQP4+ NMOSD. Show references: https://pubmed.ncbi.nlm.nih.gov/38760098/ https://www.neurology.org/doi/10.1212/NXI.0000000000200071
Apr 29, 2025 • 2min
BTK Inhibitors in Multiple Sclerosis Treatment - Part 3
In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how to address questions related to BTK Inhibitors with patients. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2415985 https://www.nejm.org/doi/full/10.1056/NEJMoa2415988
Apr 28, 2025 • 4min
BTK Inhibitors in Multiple Sclerosis Treatment - Part 2
In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss the clinical trial data available in both the relapsing and progressive cohorts. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2415985 https://www.nejm.org/doi/full/10.1056/NEJMoa2415988
Apr 24, 2025 • 4min
BTK Inhibitors in Multiple Sclerosis Treatment - Part 1
In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how Bruton Tyrosine Kinase (BTK) Inhibitors work and how they vary from other disease-modifying therapies. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2415985 https://www.nejm.org/doi/full/10.1056/NEJMoa2415988
Apr 23, 2025 • 3min
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
Dr. Justin Abbatemarco provides an update on autologous hematopoietic stem cell transplantation in multiple sclerosis. Show reference: https://www.nature.com/articles/s41582-024-01050-x
